#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glioblastoma Glycogen storage disease type II Mitochondrial encephalomyopathy Sjogren's syndrome Infection in an immunocompromised host Neuroendocrine tumour of the lung Anal fistula Soft tissue sarcoma Langerhans cell sarcoma Arteriovenous malformation Erythema Hereditary ataxia Acute myeloid leukaemia (in remission) Neuroendocrine carcinoma Dedifferentiated liposarcoma More trials…

    Learn about Rare Diseases

    Hereditary angioedema – Diagnostics Ehlers-Danlos syndrome – Trials in Disease Arterial tortuosity syndrome – Trials in Disease Paraneoplastic neurological syndrome – Treatment Acquired haemophilia – Treatment Amyotrophic lateral sclerosis – Trials in Disease Osteosarcoma recurrent – Diagnostics Hereditary neuropathic amyloidosis – Trials in Disease Hairy cell leukaemia recurrent – Diagnostics Krabbe’s disease – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clebopride Hydrogen Maleate Rotigotine Bleomycin Sulfate Ph. Eur. Prednisone Soticlestat Anthoxanthum Odoratum Rbl007.2 Paeonol Lbl-007 Tetracycline Hydrochloride Carisbamate Zinc Sulphate Heptahydrate Omx-0407 Lamotrigine Promethazine Hydrochloride [Al[18F]F]Fapi-74 Mexiletine ALLERGEN EXTRACTS Anv600 Phenylephrine More therapies…

    Learn about Your Condition

    Vulvovaginal pain Ataxia telangiectasia Knee arthroplasty Cluster headache Plasmablastic lymphoma Thalassaemia beta Bronchiolitis Transitional cell carcinoma Colonoscopy Nicotine dependence Perthes disease Skin ulcer Peripheral artery stenosis Portal hypertension Hypersomnia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Safety and Tolerability Study of Subcutaneous Pegtibatinase in Adults and Children with Classical Homocystinuria (Phase 1/2)

    Not yet recruiting

    2 1 1
    France

  • Intranasal remestemcel therapy for newborns with hypoxic‑ischemic brain injury: a phase II placebo‑controlled trial

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Brain injury
    Investigated Drugs:
    • Remestemcel
    The Netherlands

  • Phase 2/3 study of telisotuzumab adizutecan with drug combination versus standard care in adults with first‑line metastatic pancreatic ductal adenocarcinoma

    Not yet recruiting

    4 1 1 1
    Investigated Drugs:
    • Irinotecan Hydrochloride
    • Calcium Folinate
    • Fluorouracil
    Austria France Germany Italy Portugal Spain

  • Study of Camizestrant and Abemaciclib in Patients with ER‑positive HER2‑negative Metastatic Breast Cancer Who Show Rising ctDNA

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Camizestrant
    • Abemaciclib
    France

  • Methotrexate tapering versus usual care in elderly (≥70) patients with rheumatoid arthritis in low disease activity – drug combination study

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Filgotinib
    • Baricitinib
    • Certolizumab Pegol
    Denmark

  • Discontinuing Acetylsalicylic Acid vs Continued Use in Patients ≥ 65 Years with Stable Chronic Coronary Syndrome

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic coronary syndrome
    • Myocardial ischaemia
    Investigated Drugs:
    • Acetylsalicylic Acid
    Denmark
Previous Page
1 … 682 683 684 685 686 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!